Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
ARTICLES Big pharma eyes China at forefront of GLP-1 revolution Two leading glucagon-like peptide-1 (GLP-1) receptor agonists for obesity and type 2 diabetes Novo Nordisk A/Ss semaglutide (Wegovy/Ozempic) and Eli Lilly and Co.s tirzepatide (Mounjaro/Zepbound) are advancing in China after taking the U.S
Spotlight on Key Peptides The world of peptides is vast, but a few candidates are making headlines for autoimmune conditions
Spatial distribution of the pathways of cholesterol homeostasis in human retina
The process is straightforward, and were always available to answer questions and provide guidance
US$ 29.68
US$ 22.65
US$ 26.26
US$ 26.19
